Page 0008


Dexcom G6 below left, the nextgeneration

G7 on the right.



Looking to the future with Dexcom's President Kevin Sayer.

By Sue Marshall.



met with Dexcom's President

Kevin Sayer earlier this year to

talk about the coming Dexcom

G7 product which is due

become available in the UK

next year. It will supersede the current

Dexcom G6 CGM sensor. But more than

an upgrade, the entire marketplace is

also changing with 'interoperability' being

the new paradigm - bits of kit 'talking' to

each other, meters and sensors sending

data to either insulin pumps, apps (or

both) and even to the Cloud where it can

be seen by HCPs or other carers. We

started off talking about the trend towards

interoperable devices.

"Dexcom CGM sensors already talk to

more pumps than ever before," Sayer told

me. "The current Dexcom transmitter can

speak to two other devices at the same

time. Very few products can do that at

the moment. But, while sharing sounds

lovely, we also have to run our companies

well in order to stay in business and keep

our products out there. We have spent

millions on development of our products

to be sure they work and are easy to use."

Kevin Sayer, President Dexcom Inc

I mentioned that JDRF is pushing

for wide capabilities for interoperable

devices but asked Sayer, on a practical

level, how will that work? "One problem

with interoperability is, what if something

goes wrong? If there is a chain of product

suppliers even up to the phones where

apps are hosted. Somewhere in all that will

be a need for legal agreements. Ultimately

someone has to be responsible. We want

to get there, but it's not easy."

Getting connected

In our meeting I stated that Dexcom

seems to be on a roll, with no signs of

stopping as uptake of its CGM sensors

grows. I asked, what does Sayer see as

the opportunities for interoperability? He

confirmed, "Our sales have doubled in

the last two years which is a big jump.

People rely on our sensors for their health

and well-being. What we've done is bring

data to the fore, making it accessible for

users to see on apps, smartphones and

smart watches. If other devices are doing

a similar thing, such as the soon-to-beavailable connected insulin pens, then the

user can get data on insulin delivery that

goes into an app. Data going into an app

from a CGM then can take into account

such as 'insulin on board'. Then both

sets of data can go up to the Cloud so

that GPs other healthcare professionals,

partners, parents or carers can see it if


Connected pens have been the

'missing link' for many years as the insulin

suppliers are relatively speaking slow to

change. The best that the roughly 80%

continued over


  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038

Related Issues